Literature DB >> 23093457

Neuroimaging after critical illness: implications for neurorehabilitation outcome.

Ramona O Hopkins1, James C Jackson.   

Abstract

Survivors of critical illness frequently have severe and long-lasting cognitive impairments and psychiatric disorders, which adversely affect functional outcomes including return to work, and quality of life. While data regarding cognitive outcomes has increased over the last 15 years, neuroimaging data in medical and surgical critical populations is extremely limited. The abrupt development of new significant cognitive impairments after critical illness along with abnormalities on neuroimaging suggest that critical illness results in new acquired brain injury, similar to that observed in other acquired brain injuries. Abnormalities on neuroimaging including cortical and subcortical lesions, brain atrophy, and white matter hyperintensities (WMH) which occur in widely distributed brain regions. Patients admitted to neurorehabilitation who received critical care related to their primary diagnosis may have sustained neurological injury from the nonspecific effects of their critical illness and as demonstrated in this review, generalized, non-specific neuroimaging findings may be observed and quantified. Given the high prevalence rate of cognitive impairments in this population, neuroimaging is important to help elucidate neuropathology of critical illness acquired brain injury and may be beneficial in guiding rehabilitation outcomes in this population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23093457      PMCID: PMC3708645          DOI: 10.3233/NRE-2012-0798

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  37 in total

1.  Mapping out biomarkers for Alzheimer disease.

Authors:  Monique M B Breteler
Journal:  JAMA       Date:  2011-01-19       Impact factor: 56.272

2.  Temporal lobe morphology in normal aging and traumatic brain injury.

Authors:  Erin D Bigler; Carol V Anderson; Duane D Blatter; Carol V Andersob
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

3.  Cognitive and physical rehabilitation of intensive care unit survivors: results of the RETURN randomized controlled pilot investigation.

Authors:  James C Jackson; E Wesley Ely; Miriam C Morey; Venice M Anderson; Laural B Denne; Jennifer Clune; Carol S Siebert; Kristin R Archer; Renee Torres; David Janz; Elena Schiro; Julie Jones; Ayumi K Shintani; Brian Levine; Brenda T Pun; Jennifer Thompson; Nathan E Brummel; Helen Hoenig
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

4.  Effects of physical training on functional status in patients with prolonged mechanical ventilation.

Authors:  Ling-Ling Chiang; Li-Ying Wang; Chin-Pyng Wu; Huey-Dong Wu; Ying-Tai Wu
Journal:  Phys Ther       Date:  2006-09

5.  Blood glucose dysregulation and cognitive outcome in ARDS survivors.

Authors:  Ramona O Hopkins; Mary R Suchyta; Gregory L Snow; Al Jephson; Lindell K Weaver; James F Orme
Journal:  Brain Inj       Date:  2010-09-21       Impact factor: 2.311

6.  Magnetic resonance imaging abnormalities with septic encephalopathy.

Authors:  P F Finelli; D F Uphoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 7.  Short- and long-term cognitive outcomes in intensive care unit survivors.

Authors:  Ramona O Hopkins; James C Jackson
Journal:  Clin Chest Med       Date:  2009-03       Impact factor: 2.878

8.  Delirium in critical care unit patients admitted through an emergency room.

Authors:  Y Kishi; Y Iwasaki; K Takezawa; H Kurosawa; S Endo
Journal:  Gen Hosp Psychiatry       Date:  1995-09       Impact factor: 3.238

9.  Sepsis-associated encephalopathy: a magnetic resonance imaging and spectroscopy study.

Authors:  Fernando A Bozza; Philippe Garteiser; Marcus F Oliveira; Sabrina Doblas; Rebecca Cranford; Debra Saunders; Inna Jones; Rheal A Towner; Hugo C Castro-Faria-Neto
Journal:  J Cereb Blood Flow Metab       Date:  2009-10-21       Impact factor: 6.200

Review 10.  Critical care and the global burden of critical illness in adults.

Authors:  Neill K J Adhikari; Robert A Fowler; Satish Bhagwanjee; Gordon D Rubenfeld
Journal:  Lancet       Date:  2010-10-11       Impact factor: 79.321

View more
  5 in total

1.  Functional brain imaging in survivors of critical illness: A prospective feasibility study and exploration of the association between delirium and brain activation patterns.

Authors:  James C Jackson; Alessandro Morandi; Timothy D Girard; Kristen Merkle; Amy J Graves; Jennifer L Thompson; Ayumi K Shintani; Max L Gunther; Christopher J Cannistraci; Baxter P Rogers; John C Gore; Hillary J Warrington; E Wesley Ely; Ramona O Hopkins
Journal:  J Crit Care       Date:  2015-01-30       Impact factor: 3.425

2.  Brain MRI after critical care admission: A longitudinal imaging study.

Authors:  Juraj Sprung; David O Warner; David S Knopman; Ronald C Petersen; Michelle M Mielke; Clifford R Jack; David P Martin; Andrew C Hanson; Darrell R Schroeder; Scott A Przybelski; Phillip J Schulte; Mariana L Laporta; Toby N Weingarten; Prashanthi Vemuri
Journal:  J Crit Care       Date:  2020-12-05       Impact factor: 4.298

Review 3.  Myalgic Encephalomyelitis: Symptoms and Biomarkers.

Authors:  Leonard A Jason; Marcie L Zinn; Mark A Zinn
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

4.  Evolution of Cerebral Atrophy in a Patient with Super Refractory Status Epilepticus Treated with Barbiturate Coma.

Authors:  Christopher R Newey; Pravin George; Premkumar Nattanmai; Christine Ahrens; Stephen Hantus; Aarti Sarwal
Journal:  Case Rep Neurol Med       Date:  2017-01-15

5.  Patients Surviving Critical COVID-19 have Impairments in Dual-task Performance Related to Post-intensive Care Syndrome.

Authors:  Nathan Morelli; Selina M Parry; Angela Steele; Megan Lusby; Ashley A Montgomery-Yates; Peter E Morris; Kirby P Mayer
Journal:  J Intensive Care Med       Date:  2022-01-24       Impact factor: 2.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.